Literature DB >> 16336581

Increased phagocytic nicotinamide adenine dinucleotide phosphate oxidase-dependent superoxide production in patients with early chronic kidney disease.

Ana Fortuño1, Oscar Beloqui, Gorka San José, María U Moreno, Guillermo Zalba, Javier Díez.   

Abstract

BACKGROUND: Oxidative stress has been implicated in the pathogenesis of atherosclerosis that develops in patients with advanced chronic kidney disease (CKD). This study was designed to investigate whether a relationship exists between phagocytic nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-dependent superoxide anion (*O2-) production and subclinical atherosclerosis in patients with early CKD.
METHODS: Superoxide production was assayed by chemiluminescence under baseline and stimulated conditions on mononuclear cells obtained from asymptomatic patients with stage 1 to 2 CKD (N=22) and healthy controls (N=21). Ultrasonographic determination of carotid intima-media thickness (IMT) was used to assess the presence of atherosclerosis.
RESULTS: Although there were no differences in baseline *O2- production between controls and patients, the *O2- production in phorbol myristate acetate-stimulated mononuclear cells was increased (P<0.05) in patients compared with controls. The phorbol myristate acetate-induced *O2- production was completely abolished by apocynin, a specific inhibitor of NADPH oxidase. A direct correlation (r=0.441, P<0.05) was found between plasma insulin levels and NADPH oxidase-mediated *O2- production in patients. Carotid IMT was higher (P<0.005) in patients than in controls. Carotid IMT values above the upper normal limit in controls were found in 70% and 40% of patients with increased or normal NADPH oxidase-mediated *O2- production, respectively.
CONCLUSION: Generation of *O2- that is mainly dependent on NADPH oxidase is abnormally enhanced in patients with early CKD. It is suggested that this alteration could be related to the development of subclinical atherosclerosis in these patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16336581     DOI: 10.1111/j.1523-1755.2005.09913.x

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  15 in total

1.  SOD3 and IL-18 Predict the First Kidney Disease-Related Hospitalization or Death during the One-Year Follow-Up Period in Patients with End-Stage Renal Disease.

Authors:  Yu-Hsien Liu; Yu-Hsuan Chen; Chi-Hua Ko; Chia-Wen Kuo; Chih-Ching Yen; Wei Chen; Kowit-Yu Chong; Chuan-Mu Chen
Journal:  Antioxidants (Basel)       Date:  2022-06-18

2.  Serum C-reactive protein and thioredoxin levels in subjects with mildly reduced glomerular filtration rate.

Authors:  Shoko Tsuchikura; Tetsuo Shoji; Naoko Shimomura; Ryusuke Kakiya; Masanori Emoto; Hidenori Koyama; Eiji Ishimura; Masaaki Inaba; Yoshiki Nishizawa
Journal:  BMC Nephrol       Date:  2010-04-27       Impact factor: 2.388

3.  Cardiovascular Complications in CKD Patients: Role of Oxidative Stress.

Authors:  Elvira O Gosmanova; Ngoc-Anh Le
Journal:  Cardiol Res Pract       Date:  2011-01-02       Impact factor: 1.866

4.  Methionine sulfoxides in serum proteins as potential clinical biomarkers of oxidative stress.

Authors:  Satoko Suzuki; Yoshio Kodera; Tatsuya Saito; Kazumi Fujimoto; Akari Momozono; Akinori Hayashi; Yuji Kamata; Masayoshi Shichiri
Journal:  Sci Rep       Date:  2016-12-08       Impact factor: 4.379

5.  Comparative study of extrapolative factors linked with oxidative injury and anti-inflammatory status in chronic kidney disease patients experiencing cardiovascular distress.

Authors:  Mahmood Rasool; Muhammad Abdul Basit Ashraf; Arif Malik; Sulayman Waquar; Shahida Aziz Khan; Mahmood Husain Qazi; Waseem Ahmad; Muhammad Asif; Sami Ullah Khan; Ahmad Zaheer; Muther Mansoor Qaisrani; Abdul Rehman Khan; Aamir Iqbal; Amir Raza; Saima Iram; Kashif Kamran; Asim Iqbal; Mohammad Zahid Mustafa; Hani Choudhry; Mazin A Zamzami; Wesam H Abdulaal; Mohammad Sarwar Jamal
Journal:  PLoS One       Date:  2017-02-08       Impact factor: 3.240

6.  Chronic kidney disease, kidney transplantation and oxidative stress: a new look to successful kidney transplantation.

Authors:  Hossein Tabriziani; Michael S Lipkowitz; Nhan Vuong
Journal:  Clin Kidney J       Date:  2017-08-16

7.  The uremic toxin indoxyl sulphate enhances macrophage response to LPS.

Authors:  Simona Adesso; Ada Popolo; Giuseppe Bianco; Rosalinda Sorrentino; Aldo Pinto; Giuseppina Autore; Stefania Marzocco
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

Review 8.  Mitochondria: a new therapeutic target in chronic kidney disease.

Authors:  Simona Granata; Alessandra Dalla Gassa; Paola Tomei; Antonio Lupo; Gianluigi Zaza
Journal:  Nutr Metab (Lond)       Date:  2015-11-25       Impact factor: 4.169

Review 9.  Oxidative Stress in Diabetic Nephropathy with Early Chronic Kidney Disease.

Authors:  Alejandra Guillermina Miranda-Díaz; Leonardo Pazarín-Villaseñor; Francisco Gerardo Yanowsky-Escatell; Jorge Andrade-Sierra
Journal:  J Diabetes Res       Date:  2016-07-20       Impact factor: 4.011

Review 10.  Chronic Kidney Disease and Disproportionally Increased Cardiovascular Damage: Does Oxidative Stress Explain the Burden?

Authors:  Anila Duni; Vassilios Liakopoulos; Karolos-Pavlos Rapsomanikis; Evangelia Dounousi
Journal:  Oxid Med Cell Longev       Date:  2017-11-23       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.